FDA — authorised 1 August 2008
- Marketing authorisation holder: MEDICINES CO
- Status: approved
🇺🇸 Cleviprex in United States
FDA authorised Cleviprex on 1 August 2008
Marketing authorisations
FDA — authorised 1 August 2008
- Application: NDA022156
- Marketing authorisation holder: CHIESI
- Local brand name: CLEVIPREX
- Indication: EMULSION — INTRAVENOUS
- Status: approved
Cleviprex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Cleviprex approved in United States?
Yes. FDA authorised it on 1 August 2008; FDA authorised it on 1 August 2008.
Who is the marketing authorisation holder for Cleviprex in United States?
MEDICINES CO holds the US marketing authorisation.